Catalytically active human telomerase mutants with allele-specific biological properties

Experimental Cell Research

Volumn 288, Issue 2, 2003, Pages 277-287

  Kim, Moses ^a,b   Xu, Lifeng ^a   Blackburn, Elizabeth H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Human telomerase; Immortalization; IMR90 cells; Primary fibroblasts; Telomerase mutants; Telomere length; Telomeres; Viral oncogenes

Indexed keywords

ALLELE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CATALYSIS; CATALYST; CELL IMMORTALIZATION; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LIFESPAN; LUNG FIBROBLAST; MUTANT; ONCOGENE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DOMAIN; SENESCENCE; TELOMERE;

EID: 0041562482     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-4827(03)00217-9     Document Type: Article

References (58)

1. Hayflick L., Moorhead P.S. The serial cultivation of human diploid cell strains. Exp. Cell Res. 25:1961;585-621.
2. Hayflick L. Tissue cultures and mycoplasmas. Tex. Rep. Biol. Med. 23:(Suppl 1):1965;285+.
3. Bowman P.D., Meek R.L., Daniel C.W. Aging of human fibroblasts in vitro. Correlations between DNA synthetic ability and cell size. Exp. Cell Res. 93:1975;184-190.
4. Sherwood S.W., Rush D., Ellsworth J.L., Schimke R.T. Defining cellular senescence in IMR-90 cells a flow cytometric analysis . Proc. Natl. Acad. Sci. USA. 85:1988;9086-9090.
5. Counter C.M., Hahn W.C., Wei W., Caddle S.D., Beijersbergen R.L., Lansdorp P.M., Sedivy J.M., Weinberg R.A. Dissociation among in vitro telomerase activity, telomere maintenance, and cellular immortalization. Proc. Natl. Acad. Sci. USA. 95:1998;14723-14728.
6. Romanov S.R., Kozakiewicz B.K., Holst C.R., Stampfer M.R., Haupt L.M., Tlsty T.D. Normal human mammary epithelial cells spontaneously escape senescence and acquire genomic changes. Nature. 409:2001;633-637.
7. Zhu J., Wang H., Bishop J.M., Blackburn E.H. Telomerase extends the lifespan of virus-transformed human cells without net telomere lengthening. Proc. Natl. Acad. Sci. USA. 96:1999;3723-3728.
8. Shay J.W., Wright W.E. Quantitation of the frequency of immortalization of normal human diploid fibroblasts by SV40 large T-antigen. Exp. Cell Res. 184:1989;109-118.
9. Bryan T.M., Englezou A., Gupta J., Bacchetti S., Reddel R.R. Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J. 14:1995;4240-4248.
10. Murnane J.P., Sabatier L., Marder B.A., Morgan W.F. Telomere dynamics in an immortal human cell line. EMBO J. 13:1994;4953-4962.
11. Hahn W.C., Counter C.M., Lundberg A.S., Beijersbergen R.L., Brooks M.W., Weinberg R.A. Creation of human tumour cells with defined genetic elements. Nature. 400:1999;464-468.
12. Blackburn E.H. The end of the (DNA) line. Nat. Struct. Biol. 7:2000;847-850.
13. Bodnar A.G., Ouellette M., Frolkis M., Holt S.E., Chiu C.P., Morin G.B., Harley C.B., Shay J.W., Lichtsteiner S., Wright W.E. Extension of life-span by introduction of telomerase into normal human cells. Science. 279:1998;349-352.
14. Blackburn E.H. Switching and signaling at the telomere. Cell. 106:2001;661-673.
15. Griffith J.D., Comeau L., Rosenfield S., Stansel R.M., Bianchi A., Moss H., de Lange T. Mammalian telomeres end in a large duplex loop. Cell. 97:1999;503-514.
16. Enomoto S., Glowczewski L., Berman J. MEC3, MEC1, and DDC2 are essential components of a telomere checkpoint pathway required for cell cycle arrest during senescence in Saccharomyces cerevisiae. Mol. Biol. Cell. 13:2002;2626-2638.
17. Nautiyal S., DeRisi J.L., Blackburn E.H. The genome-wide expression response to telomerase deletion in Saccharomyces cerevisiae. Proc. Natl. Acad. Sci. USA. 99:2002;9316-9321.
18. Vulliamy T., Marrone A., Goldman F., Dearlove A., Bessler M., Mason P.J., Dokal I. The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita. Nature. 413:2001;432-435.
19. Comolli L.R., Smirnov I., Xu L., Blackburn E.H., James T.L. A molecular switch underlies a human telomerase disease. Proc. Natl. Acad. Sci. USA. 99:2002;16998-17003.
20. Mitchell J.R., Wood E., Collins K. A telomerase component is defective in the human disease dyskeratosis congenita. Nature. 402:1999;551-555.
21. Vulliamy T., Marrone A., Dokal I., Mason P.J. Association between aplastic anaemia and mutations in telomerase RNA. Lancet. 359:2002;2168-2170.
22. Ducray C., Pommier J.P., Martins L., Boussin F.D., Sabatier L. Telomere dynamics, end-to-end fusions and telomerase activation during the human fibroblast immortalization process. Oncogene. 18:1999;4211-4223.
23. Yang J., Chang E., Cherry A.M., Bangs C.D., Oei Y., Bodnar A., Bronstein A., Chiu C.P., Herron G.S. Human endothelial cell life extension by telomerase expression. J. Biol. Chem. 274:1999;26141-26148.
24. Vaziri H., Benchimol S. Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span. Curr. Biol. 8:1998;279-282.
25. Ouellette M.M., Aisner D.L., Savre-Train I., Wright W.E., Shay J.W. Telomerase activity does not always imply telomere maintenance. Biochem. Biophys. Res. Commun. 254:1999;795-803.
26. Morgenstern J.P., Land H. Advanced mammalian gene transfer high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line . Nucleic Acids Res. 18:1990;3587-3596.
27. Counter C.M., Avilion A.A., LeFeuvre C.E., Stewart N.G., Greider C.W., Harley C.B., Bacchetti S. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J. 11:1992;1921-1929.
28. Shay J.W., Pereira-Smith O.M., Wright W.E. A role for both RB and p53 in the regulation of human cellular senescence. Exp. Cell Res. 196:1991;33-39.
29. Xia J., Peng Y., Mian I.S., Lue N.F. Identification of functionally important domains in the N-terminal region of telomerase reverse transcriptase. Mol. Cell. Biol. 20:2000;5196-5207.
30. Armbruster B.N., Banik S.S., Guo C., Smith A.C., Counter C.M. N-terminal domains of the human telomerase catalytic subunit required for enzyme activity in vivo. Mol. Cell. Biol. 21:2001;7775-7786.
31. Beattie T.L., Zhou W., Robinson M.O., Harrington L. Functional multimerization of the human telomerase reverse transcriptase. Mol. Cell. Biol. 21:2001;6151-6160.
32. Beattie T.L., Zhou W., Robinson M.O., Harrington L. Polymerization defects within human telomerase are distinct from telomerase RNA and TEP1 binding. Mol. Biol. Cell. 11:2000;3329-3340.
33. Weinrich S.L., Pruzan R., Ma L., Ouellette M., Tesmer V.M., Holt S.E., Bodnar A.G., Lichtsteiner S., Kim N.W., Trager J.B., Taylor R.D., Carlos R., Andrews W.H., Wright W.E., Shay J.W., Harley C.B., Morin G.B. Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT. Nature Genet. 17:1997;498-502.
34. Bryan T.M., Goodrich K.J., Cech T.R. Telomerase RNA bound by protein motifs specific to telomerase reverse transcriptase. Mol. Cell. 6:2000;493-499.
35. Bryan T.M., Goodrich K.J., Cech T.R. A mutant of Tetrahymena telomerase reverse transcriptase with increased processivity. J. Biol. Chem. 275:2000;24199-24207.
36. Bosoy D., Lue N.F. Functional analysis of conserved residues in the putative "finger" domain of telomerase reverse transcriptase. J. Biol. Chem. 276:2001;46305-46312.
37. Hardy C.D., Schultz C.S., Collins K. Requirements for the dGTP-dependent repeat addition processivity of recombinant Tetrahymena telomerase. J. Biol. Chem. 276:2001;4863-4871.
38. Cohn M., Blackburn E.H. Telomerase in yeast. Science. 269:1995;396-400.
39. Lingner J., Cech T.R., Hughes T.R., Lundblad V. Three Ever Shorter Telomere (EST) genes are dispensable for in vitro yeast telomerase activity. Proc. Natl. Acad. Sci. USA. 94:1997;11190-11195.
40. Evans S.K., Lundblad V. Est1 and Cdc13 as comediators of telomerase access. Science. 286:1999;117-120.
41. Seto A.G., Livengood A.J., Tzfati Y., Blackburn E.H., Cech T.R. A bulged stem tethers Est1p to telomerase RNA in budding yeast. Genes Dev. 16:2002;2800-2812.
42. Zhang X., Mar V., Zhou W., Harrington L., Robinson M.O. Telomere shortening and apoptosis in telomerase-inhibited human tumor cells. Genes Dev. 13:1999;2388-2399.
43. McEachern M.J., Blackburn E.H. Runaway telomere elongation caused by telomerase RNA gene mutations. Nature. 376:1995;403-409.
44. McEachern M.J., Blackburn E.H. Consequences of mutations that alter telomeres in the yeast K. lactis. Mihich E., Hartwell L. Pezcoller Foundation Symposia No. 8 Genomic Instability and Immortality in Cancer . 1997;111-127 Plenum, New York, NY. Vol. 8.
45. Marcand S., Brevet V., Mann C., Gilson E. Cell cycle restriction of telomere elongation. Curr. Biol. 10:2000;487-490.
46. Sprung C.N., Afshar G., Chavez E.A., Lansdorp P., Sabatier L., Murnane J.P. Telomere instability in a human cancer cell line. Mutat. Res. 429:1999;209-223.
47. Hemann M.T., Strong M.A., Hao L.Y., Greider C.W. The shortest telomere, not average telomere length, is critical for cell viability and chromosome stability. Cell. 107:2001;67-77.
48. Liu Y., Kha H., Ungrin M., Robinson M.O., Harrington L. Preferential maintenance of critically short telomeres in mammalian cells heterozygous for mTert. Proc. Natl. Acad. Sci. USA. 99:2002;3597-3602.
49. E. Blackburn, A. Bhattacharyya, D. Gilley, K. Kirk, A. Krauskopf, M.J. McEachern, J. Prescott, T. Ware, The telomere and telomerase: how do they interact? in: Telomeres and Telomerase, Ciba Found Symp. 211, Wiley, New York, 1997, pp. 2-19.
50. Prescott J., Blackburn E.H. Telomerase RNA mutations in Saccharomyces cerevisiae alter telomerase action and reveal nonprocessivity in vivo and in vitro. Genes Dev. 11:1997;528-540.
51. Prescott J.C., Blackburn E.H. Telomerase RNA template mutations reveal sequence-specific requirements for the activation and repression of telomerase action at telomeres. Mol. Cell. Biol. 20:2000;2941-2948.
52. Roy J., Fulton T.B., Blackburn E.H. Specific telomerase RNA residues distant from the template are essential for telomerase function. Genes Dev. 12:1998;3286-3300.
53. Strahl C., Blackburn E.H. Effects of reverse transcriptase inhibitors on telomere length and telomerase activity in two immortalized human cell lines. Mol. Cell. Biol. 16:1996;53-65.
54. Ouellette M.M., Liao M., Herbert B.S., Johnson M., Holt S.E., Liss H.S., Shay J.W., Wright W.E. Subsenescent telomere lengths in fibroblasts immortalized by limiting amounts of telomerase. J. Biol. Chem. 275:2000;10072-10076.
55. Diede S.J., Gottschling D.E. Telomerase-mediated telomere addition in vivo requires DNA primase and DNA polymerases alpha and delta. Cell. 99:1999;723-733.
56. Taggart A.K., Teng S.C., Zakian V.A. Est1p as a cell cycle-regulated activator of telomere-bound telomerase. Science. 297:2002;1023-1026.
57. C.D. Smith, D.L. Smith, J.L. DeRisi, E.H. Blackburn, Telomeric protein distributions and remodeling through the cell cycle in S. cerevisiae, Mol. Biol. Cell, 14 (2002) 556-570.
58. Nakamura T.M., Morin G.B., Chaprnan K.B., Weinrich S.L., Andrews W.H., Lingner J., Harley C.B., Cech T.R. Telomerase catalytic subunit homologs from fission yeast and human. Science. 277:1997;955-959.